MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with L

Lurasidone

Lurasidone 18.5mg tablets

Use with caution

Stability notes for Lurasidone 18.5mg tablets

Light sensitive medicine. Store in light resistant container.   No stability data in MCAs available.

Provenance

This recommendation is based on the products Latuda 18.5mg film-coated tablets (CNX Therapeutics Ltd) and Lurasidone 18.5mg film-coated tablets (Aspire Pharma Ltd).

Suppliers (8) of Lurasidone 18.5mg tablets
Latuda 18.5mg tablets (CNX Therapeutics Ltd)
Latuda 18.5mg tablets (CST Pharma Ltd)
Lurasidone 18.5mg tablets (A A H Pharmaceuticals Ltd)
Lurasidone 18.5mg tablets (Accord-UK Ltd)
Lurasidone 18.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Lurasidone 18.5mg tablets (Aspire Pharma Ltd)
Lurasidone 18.5mg tablets (Dexcel-Pharma Ltd)
Lurasidone 18.5mg tablets (Medical Valley Invest AB)

Lurasidone 37mg tablets

Use with caution

Stability notes for Lurasidone 37mg tablets

Light sensitive medicine. Store in light resistant container.   No stability data in MCAs available.

Provenance

This recommendation is based on the products Latuda 37mg film-coated tablets (CNX Therapeutics Ltd) and Lurasidone 37mg film-coated tablets (Aspire Pharma Ltd).

Suppliers (9) of Lurasidone 37mg tablets
Latuda 37mg tablets (Abacus Medicine Ltd)
Latuda 37mg tablets (CNX Therapeutics Ltd)
Latuda 37mg tablets (CST Pharma Ltd)
Lurasidone 37mg tablets (A A H Pharmaceuticals Ltd)
Lurasidone 37mg tablets (Accord-UK Ltd)
Lurasidone 37mg tablets (Alliance Healthcare (Distribution) Ltd)
Lurasidone 37mg tablets (Aspire Pharma Ltd)
Lurasidone 37mg tablets (Dexcel-Pharma Ltd)
Lurasidone 37mg tablets (Medical Valley Invest AB)

Lurasidone 74mg tablets

Use with caution

Stability notes for Lurasidone 74mg tablets

Light sensitive medicine. Store in light resistant container.   No stability data in MCAs available.

Provenance

This recommendation is based on the products Latuda 74mg film-coated tablets (CNX Therapeutics Ltd) and Lurasidone 74mg film-coated tablets (Aspire Pharma Ltd).

Suppliers (8) of Lurasidone 74mg tablets
Latuda 74mg tablets (CNX Therapeutics Ltd)
Latuda 74mg tablets (CST Pharma Ltd)
Lurasidone 74mg tablets (A A H Pharmaceuticals Ltd)
Lurasidone 74mg tablets (Accord-UK Ltd)
Lurasidone 74mg tablets (Alliance Healthcare (Distribution) Ltd)
Lurasidone 74mg tablets (Aspire Pharma Ltd)
Lurasidone 74mg tablets (Dexcel-Pharma Ltd)
Lurasidone 74mg tablets (Medical Valley Invest AB)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.